Ask AI

A Discussion With Experts on the Evolving Therapeutic Landscape in T-Cell Lymphomas: Focus on EZH1/2 Inhibitors

Get up to date on the optimal use of EZH1/2 inhibitors in PTCL with this expert-authored commentary plus downloadable slides and on-demand webcast from a live CCO symposium at ASCO 2022.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.